Hershey Trust CO Adverum Biotechnologies, Inc. Transaction History

Hershey Trust CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$2.08 - $3.6 $7,716 - $13,356	-3,710 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$9.26 - $14.36 $241,704 - $374,824	-26,102 Reduced 87.56%	3,710 $37,000
Q4 2020 Jan 21, 2021	BUY	$9.84 - $14.26 $293,350 - $425,119	29,812 New	29,812 $323,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $680M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Hershey Trust CO, based on Form 13F filings with the SEC.

Stay updated on Hershey Trust CO with notifications on news.